Dr. Denis Blondin

Claim this profile

Centre de recherche du CHUS

Studies Type 2 Diabetes
Studies Prediabetes
2 reported clinical trials
3 drugs studied

Affiliated Hospitals

Image of trial facility.
Centre De Recherche Du CHUS

Clinical Trials Denis Blondin is currently running

Image of trial facility.

Afternoon vs Morning Exercise

for Prediabetes

Exercise is well-known to improve skeletal muscle energy metabolism and is an established intervention to improve muscle insulin sensitivity and to counter the development of type 2 diabetes (T2D). However, given the 24h rhythmicity in substrate metabolism previously observed in healthy, lean men and the lack of such rhythmicity in men with insulin-resistance, the investigator hypothesize that appropriate timing of exercise training can maximize the metabolic health effects of exercise. Indeed, a preliminary study in humans revealed that afternoon high-intensity interval training (HIIT) exercise was more effective than morning exercise in improving 24h blood glucose levels in men with T2D. Another recent study in mice showed that the time of day is a critical factor in augmenting the beneficial effects of exercise on the skeletal muscle metabolome as well as on whole-body energy homeostasis. However, human studies that specifically target the impact of timing of exercise training on glucose homeostasis and metabolic health are scarce and the potential underlying mechanisms largely unknown. The overarching goals of this project is to improve 24-hour rhythmicity of metabolism in men and women with prediabtes by appropriate timing of exercise and to assess its effect on metabolic health and immune response. Acute and prolonged exercise interventions timed in the morning vs late afternoon will be carried out in individuals with prediabetes to determine whether acute exercise in the afternoon and prolonged exercise training in the afternoon can improve peripheral insulin sensitivity, compared to exercise in the morning, and positively affect adipose tissue dietary fatty acid storage and partitioning of dietary fatty acids in skeletal muscles.
Recruiting1 award N/A4 criteria

More about Denis Blondin

Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Denis Blondin has experience with
  • Bisoprolol Fumarate
  • Mirabegron
  • High-intensity Interval Training

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Denis Blondin specialize in?
Denis Blondin focuses on Type 2 Diabetes and Prediabetes. In particular, much of their work with Type 2 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Denis Blondin currently recruiting for clinical trials?
Yes, Denis Blondin is currently recruiting for 1 clinical trial in Sherbrooke Quebec. If you're interested in participating, you should apply.
Are there any treatments that Denis Blondin has studied deeply?
Yes, Denis Blondin has studied treatments such as Bisoprolol Fumarate, Mirabegron, High-intensity interval training.
What is the best way to schedule an appointment with Denis Blondin?
Apply for one of the trials that Denis Blondin is conducting.
What is the office address of Denis Blondin?
The office of Denis Blondin is located at: Centre de recherche du CHUS, Sherbrooke, Quebec J1H 5N4 Canada. This is the address for their practice at the Centre de recherche du CHUS.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.